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Lifespan-extending caloric restriction or mTOR inhibition impair
adaptive immunity of old mice by distinct mechanisms
Emily L. Goldberg,1,2 Melissa J. Romero-Aleshire,3 Kristin
R. Renkema,1 Melissa S. Ventevogel,4 Wade M. Chew,5
Jennifer L. Uhrlaub,1 Megan J. Smithey,1 Kirsten H.
Limesand,2,5 Gregory D. Sempowski,4 Heddwen L. Brooks3
and Janko Nikolich-
Zugich1,2,5
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Rapamycin
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Summary
Aging of the world population and a concomitant increase in agerelated diseases and disabilities mandates the search for strategies to increase healthspan, the length of time an individual lives
healthy and productively. Due to the age-related decline of the
immune system, infectious diseases remain among the top 5–10
causes of mortality and morbidity in the elderly, and improving
immune function during aging remains an important aspect of
healthspan extension. Calorie restriction (CR) and more recently
rapamycin (rapa) feeding have both been used to extend lifespan
in mice. Preciously few studies have actually investigated the
impact of each of these interventions upon in vivo immune
defense against relevant microbial challenge in old organisms.
We tested how rapa and CR each impacted the immune system in
adult and old mice. We report that each intervention differentially altered T-cell development in the thymus, peripheral T-cell
maintenance, T-cell function and host survival after West Nile
virus infection, inducing distinct but deleterious consequences to
the aging immune system. We conclude that neither rapa feeding
nor CR, in the current form/administration regimen, may be
optimal strategies for extending healthy immune function and,
with it, lifespan.
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central memory T cells, CD62Lhi44hi
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Introduction
As the world’s population grows older, it is critical to understand
comorbidities of aging and identify potential points of intervention to
improve the quality of life in older adults. Despite vast improvements in
health care, the aged population remains disproportionally vulnerable to
infectious diseases and exhibits reduced vaccine efficacy (Gardner &
Pabbatireddy, 2004). Age-related decline of immune function underlies
this critical vulnerability.
Aging is associated with several changes in the immune system,
collectively referred to as immune senescence [rev. in (Nikolich-Zugich,
2012)]. Thymic involution is the earliest sign of immune aging, starting in
early adolescence (Yang et al., 2009; Chinn et al., 2012). This leads to
decreased export of na€ıve T cells to the periphery, putting a stress upon
the peripheral maintenance of the T-cell pools [rev. in (Sprent & Surh,
2011)]. Maintaining a balanced T-cell pool with adequate na€ıve and
memory cell reserves is critical for protection against new and previously
encountered pathogens, respectively [rev. in Nikolich-Zugich (2014)].
Yet, pathogen exposure throughout the lifetime converts many na€ıve T
cells into memory cells, while the na€ıve T cells are themselves not being
properly renewed. This leads to a declining na€ıve: memory T-cell ratio
during aging. In addition, both CD4 and CD8 T cells have been shown to
exhibit cell-intrinsic age-related defects in mice and humans (NikolichZugich, 2014) some of which were associated with mortality from acute
infection with Listeria monocytogenes (Lm) (Smithey et al., 2011), West
Nile virus (WNV) (Brien et al., 2009) and Streptococcus pneumoniae
(Shivshankar et al., 2011). This has been attributed (in part) to decreased
proliferation of Ag-specific T cells (Po et al., 2002; Smithey et al., 2011),
which compounds their defective ability to produce effector cytokines
upon infection in vivo (Brien et al., 2009).
Calorie restriction (CR) is the only natural intervention known to
extend lifespan (Masoro, 2009). CR is typically defined as a 20–40%
reduction in caloric intake compared to ad libitum feeding, providing a
limitation in calories in the absence of malnutrition (essential micronutrients are provided at 100% level). Broad benefits of CR in aging
rodents include improved cardiovascular, neurological, muscular, and
skeletal health [rev in (Fontana et al., 2010)]. CR was shown to impact
immune cell function [rev. in Nikolich-Zugich & Messaoudi (2005)] by
preserving thymic cellularity during aging (Yang et al., 2009) and
perhaps consequently contributing to an increased proportion of na€ıve
CD8 T cells later in life (Yang et al., 2009). Whether CR improves
immune function against live microbial challenge is incompletely
understood. The few studies using pathogen challenge in vivo showed
that CR may increase susceptibility to infectious diseases (Sun et al.,
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We next determined the effects of each treatment on T-cell
development in the thymus. A well-documented thymic involution with
aging was found (Fig. 1A), and in agreement with previous reports
(Chen et al., 1998), CR was able to partially mitigate this loss of thymic
cellularity with age (Fig. 1B, shown as the % of cellularity from agematched control mice, harvested at the same time; absolute counts
provided in Table S1). However, both adult (A) and old (O) mice treated
with a high dose of rapa (2.5 mg kg 1 day 1 i.p.) exhibited severe loss of
thymic cellularity. In mice fed rapa-containing chow, drug blood levels
were substantially lower compared to high dose (Fig. 1D), and only the
O mice showed significant reduction of thymic cellularity compared to
controls (Fig. 1B). Thymocyte subset distribution did not appear altered
by rapa at any dose, based on the expected and equal distribution of
CD8-4- double-negative (DN), CD8 + 4 + double-positive (DP), and the
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Results
To determine how lifespan-extending interventions impact the aging
immune system, we compared the effects of lifelong CR or 60-day
rapa feeding to age-matched control male C57BL/6 mice at least
18 months old at the time of analysis. These treatment regimens were
chosen based on their ability to increase median and maximal lifespan
in mice (Harrison et al., 2009; Masoro, 2009). We are aware that the
differences in length of treatment and the age at which treatments
were initiated may have influenced our observations and have tried to
highlight those considerations accordingly. Initial gross observations
revealed no obvious physical detriments with either treatment
compared to controls. Mice on rapa exhibited slightly reduced body
weight compared to age-matched controls (Fig. S1A), probably due to
potent lipolytic effect of rapa (Harrison et al., 2009), although this
effect is known to depend on the duration of treatment (Fang et al.,
2013). CR mice exhibited the expected decline in body weight and
food intake compared to both control and rapa-treated old mice
(Fig. S1A, B).
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2001; Gardner, 2005; Kristan, 2007), despite its ‘beneficial’ impact upon
steady-state immunity and in vitro immune response. Notably, the
infection models used in these studies resulted in death of CR mice early
postinfection, reflecting defects in the innate immune system. Also, the
primary infection model used in CR mice was influenza A virus (IAV)
(Effros et al., 1991; Gardner, 2005), which in mice induces wasting and
significant weight loss, potentially confounding the survival in mice that
have no spare weight to lose. Overall, it remains unclear whether CR
alters the ability of the adaptive immune system to protect mice from
infection in vivo.
Rapa was recently used to extend lifespan in genetically heterogeneous mice, even when initiated late in life (Harrison et al., 2009; Zhang
et al., 2013). This immune suppressant specifically inhibits the mTORC1
signaling complex, which has long been considered a regulator of
lifespan (Johnson et al., 2013). This landmark discovery highlighted the
possibility of using pharmaceutical interventions to extend lifespan in
mammals. To date, only a single study has investigated the effect of rapa
feeding on immune protection in old mice (Hinojosa et al., 2012) and
demonstrated that rapa-treated old mice exhibited improved survival
following pneumococcal infection. Mice die from pneumococcal pneumonia infection within 4 days of infection, before the development of
measurable Ag-specific responses, so these authors (Hinojosa et al.,
2012) could not evaluate Ag-specific immunity, leaving the question of
how adaptive immunity in old mice is altered by lifespan-extending rapa
treatment unresolved.
This highlights a critical question: Do lifespan-extending interventions
only extend lifespan or do they also extend ‘healthspan’ (the length of
healthy, high quality lifespan)? Here, we approached this question by
interrogating the impact of CR and rapa feeding on the aging immune
system under the conditions of lethal infectious challenge. We report
that rapa and CR treatments have opposite effects on thymic cellularity,
peripheral homeostasis, and subset balance of na€ıve and memory T-cell
subsets. Perhaps most importantly, CR mice exhibited significantly
increased mortality from WNV infection and poor Ag-specific T-cell
function, with the mortality of rapa-treated group trending lower, but
not reaching statistical significance. We conclude that thorough examination of immune function is essential to evaluate whether lifespan
extension interventions can improve healthspan and that both rapa and
CR, during prolonged administration, impose additional immunological
defects during aging.

Fig. 1 Rapamycin and calorie restriction have different effects on thymic cellularity.
Mice were placed on rapa for 2 months or on CR for life. (A) Untreated A and O
mouse thymus cellularity. (B) Thymi were harvested from A and O mice from the
indicated treatment groups and total thymocytes enumerated. (C) Thymus single-cell
suspensions were analyzed for thymocyte development based on CD4 and CD8
expression. (D) Whole blood rapa concentration was measured in O mice being
treated with the indicated doses and routes. Data represent the combination of 2
independent experiments, with n = 2–5 mice per replicate. (B) Thymic cellularity is
represented as % of age-matched controls that were harvested at the same time, to
control for different dosing routes. 2.5 mg kg 1 and 75 lg kg 1 were given as daily
i.p. injections. 14 ppm was the concentration of rapa in rodent chow, as described in
the experimental procedures section. Statistical differences were calculated by
Student’s t-tests compared to the cellularity of age-matched, control-treated mice.
(C-D) Statistical differences were calculated by 1-way ANOVA with Bonferroni’s posttests. *P<0.05; **P<0.01; ***P<0.001.
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testosterone levels during puberty are associated with thymus involution
(Chinn et al., 2012), and castration early in life preserves thymic
cellularity (Radojevic et al., 2007), although it is also clear that sex
steroids alone do not causally and singlehandedly cause thymic
involution (Chinn et al., 2012; Griffith et al., 2012). We conclude that
rapa and CR have significant and opposite effects on the thymus and
T-cell development.
We next examined whether the above alterations in thymic cellularity
affected peripheral T-cell pools. We first enumerated blood T-cell
subsets, finding the expected general lymphopenia in O mice on CR,
which was not caused by T-cell (total CD4 or CD8) depletion (Fig. 2A).
Within the CD4 T-cell compartment, O CR mice had significantly more
na€ıve (N; CD44lowCD62Lhi) CD4 T cells and regulatory T cells (Tregs,
FoxP3+) compared to controls (Fig. 2B). Despite an increased relative
frequency of N CD8 T cells in CR mice compared to controls (Fig. S3)
absolute numbers of N CD8 T cells in the blood were similar in all three
groups of O mice (control, rapa, CR, Fig. 2C). CR mice exhibited lower
cell counts of CD8 central memory (CM, CD44hiCD62Lhi) and effector
memory (EM, CD44hiCD62Llow) cells, whereas rapa had no effect upon
these subsets. Overall, we conclude that in O mice CR significantly alters
blood T-lymphocyte population abundance during aging.

CD4 and CD8 single-positive subsets between groups (Fig. 1C), each of
which marks a discrete stage of thymocyte maturation. This suggested
that the individual treatments did not induce specific developmental
blocks, impacting all subsets symmetrically, or perhaps impacting only
some of the earliest precursors (e.g., HSC or early T-cell precursors). We
did not further investigate high-dose rapa treatment, because it is not
used to extend longevity and due to its highly deleterious effects on the
thymus. We focused upon the rapa chow, which in our hands produced
rapa blood levels similar to rapa levels in transplant patients taking
sirolimus (Mahe et al., 2005), although in genetically heterogeneous
mice, rapa feeding results in blood levels 39 than that of patients
(Harrison et al., 2009).
At this point, we considered the possibility that CR and rapa
treatments may alter hormones known to impact the thymus. Rapa
feeding has been reported to accelerate testicular degeneration in O
male mice (Wilkinson et al., 2012), and androgens are known to
significantly impact thymocyte survival (Min et al., 2006; Radojevic et al.,
2007). Therefore, we measured serum testosterone levels in control and
rapa age-matched O mice. Mice treated with rapa exhibited significantly
increased serum testosterone levels (Fig. S2). This change could
modulate and pronounce the decreased thymic cellularity, as increasing
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and/or trafficking. Overall, our data indicate that rapa and CR induce
distinct differences in peripheral CD8 T-cell subset maintenance.
Because rapa feeding and CR exerted different effects on absolute
counts of T-cell subsets in the periphery, we asked whether the changes
in representation of cells undergoing steady-state proliferation were
caused by changes in absolute numbers of cycling cells in each subset.
Old N CD4 and CD8 T cells were sensitive to rapa’s antiproliferative
effect, as judged by a decreased number of such cells expressing Ki-67
(Fig. S4A, B) compared to O control cells. However, numbers of Ki-67+
CD4 Treg cells and CD8 effector memory cells did not change in O mice
regardless of rapa treatment (Fig. S4A, B). This is in contrast to significant
changes in the frequencies of Ki-67+ cells within these subsets (Fig. 3A,
B), suggesting that rapa treatment decreases the nonproliferating
fraction of these of Tregs and CD8 EM cells, by redistribution to other
organs or by true depletion. Conversely, although the frequency of CD8
CM Ki-67+ cells was decreased by rapa feeding, this was not due to a
decline in the number of cells within this subset (Fig. S4B). We conclude
that na€ıve T cells appear particularly susceptible to the rapa-mediated cell
cycle inhibition; the significant increase in the fraction of proliferating
Treg and CD8 effector memory in O CR mice is likely due to the relative
overrepresentation of these cells (Fig. S4B, C, respectively).
It was surprising that higher thymocyte counts found in O CR mice
failed to translate into increased numbers of na€ıve CD8 T cells in the
periphery. To determine whether the altered thymic cellularity in each
treatment group also changed thymic output of CD8 T cells, we

We also examined whether the above treatments impacted homeostatic behavior of peripheral T-cell subsets, by testing cycling rates of
these cells by measuring Ki-67, a nuclear protein expressed by actively
proliferating cells, within each subset. While N CD4 T-cell steady-state
proliferation was not altered by rapa or CR, significantly fewer Tregs
were in cycle in CR O mice (Fig. 3A) compared to O controls. In all three
groups, very few N CD8 T cells were Ki-67+ and this was further reduced
by rapa (Fig. 3B). Surprisingly, we observed a substantial increase in the
abundance of Ki-67+ EM CD8 T cells in CR mice compared to both
control and rapa groups (Fig. 3B). Therefore, the few EM cells (Fig 2C) in
CR-treated mice were highly proliferative, suggesting that these cells in
CR mice turn over vigorously. It remains to be seen whether this turnover
is stimulated by homeostatic (e.g., relative IL-15 abundance) or other,
perhaps antigen-driven, mechanisms. Rapa treatment decreased the
abundance of the Ki-67+ CM subset compared to both control and CR,
suggesting that this subset could be pushed to quiescence by mTOR
inhibition. Although we had not intended to directly compare metabolic
signaling/requirements in T-cell subsets, the different effects of each
treatment on different subsets supports the hypothesis that distinct T-cell
populations have different metabolism and will thus respond differently
to treatment. Overall, the impact on the fraction of proliferating cells at
steady state was directly opposite to the abundance of the given subset;
in other words, abundant subsets tended to turn over less vigorously in O
treated mice, and these values were similar to untreated A mice. It will
be important to examine the impact of rapa and CR upon cell survival
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Fig. 4 Rapamycin and calorie restriction do not alter thymic output. Spleen and
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NS4b were quantified. (C) Memory phenotype within the NS4b-specific CD8 T-cell
precursors was measured. (B-C) Data are shown as mean  SEM and are
combined from 3 independent harvests, each with n = 2–3 mice/group at each
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nonparametric Kruskal–Wallis test with Dunn’s multiple comparison test. Adults
are shown only as a reference point and were not included in statistical analyses.
(B, C) Statistical differences were calculated by 1-way ANOVA with Bonferroni’s
post-test

quantified T-cell receptor excision circles (TRECs; a by-product of TCR
gene rearrangement that remain in the cell episomally, used to estimate
thymic output of cells (Sempowski et al., 2002) from enriched CD8 T
cells in the spleen and superficial lymph nodes. In contrast to previous
reports on CD4 T cells in CR (Yang et al., 2009), we found no difference
in CD8 T-cell TRECs in rapa or CR O mice compared to age-matched
controls (Fig. 4A). Therefore, the CR-mediated improvement in thymic
cellularity did not result in increased CD8 T-cell export to the periphery.
To confirm and extend these observations, we directly quantified
antigen-specific CD8 T-cell precursors from the spleen and superficial
lymph nodes of unimmunized mice (Moon et al., 2007). Again, CR and
rapa mice had the same number of CD8 cells specific for the West Nile
virus (WNV) class I immunodominant epitope, NS4b (Brien et al., 2009) as
did the control O mice (Fig. 4B), despite dramatic differences in thymic
cellularity (Fig. 1B). In aging, many na€ıve precursors become CD44hi
virtual memory cells despite never encountering antigen, becoming
functionally inferior to truly na€ıve CD44low precursors [rev. in Nikolich
Zugich (2014)]. NS4b virtual memory precursors in CR and rapa mice
were numerically comparable to untreated O controls (Fig. 4C). Thus, the
equal numbers and the equal content of memory-phenotype precursors
in all groups were consistent with the equal TRECs content.
Finally, we asked whether the treatment by rapa or CR alters immune
protection against infection, by infecting O control, O rapa, and O CR
mice with 1000 pfu WNV s.c., a dose that killed >60% of O control

Fig. 5 Calorie restriction, but not rapamycin, increases WNV mortality in old mice.
Mice were infected with 103 pfu WNV s.c. and tracked 30 days after infection or
sacrificed on day 10 postinfection for Ag-specific T-cell analysis. (A) Survival after WNV
infection in O, O rapa, and O CR mice. (B) Total number of NS4b-specific CD8 T cells
that produce IFNc upon ex vivo peptide stimulation. (C) Total number of CD4 T cells
that produce IFNc after ex vivo peptide stimulation with a pool of CD4 epitopes as
indicated in the materials and methods. (D) Adult control and CR mice were infected
with 103 pfu WNV and tracked for survival. (A) Data shown are the combination of 3
independent experiments (n = 9–12 mice/group in each experiment). Statistical
differences were calculated by log-rank test. (B, C) Data are shown as mean  SEM
and are representative of 2 independent experiments each containing n = 12 mice/
group. Statistical differences were calculated by nonparametric Kruskal–Wallis test
with Dunn’s multiple comparison test. (D) Data shown are the combination of 2
independent experiments with n = 19 mice/group total. Statistical differences were
calculated by log-rank test. *P<0.05; **P<0.01; ***P<0.001.

mice. CR mice were significantly more susceptible to lethal WNV
meningoencephalitis compared to O controls (P = 0.0029) (Fig. 5A).
Rapa mice exhibited lower, but not statistically significant, survival
compared to controls (P = 0.1015), a point discussed below. Because
both CD4 and CD8 T cells are critically important for protection against
WNV (Sitati & Diamond, 2006; Brien et al., 2009), we also evaluated
WNV-specific T-cell responses. In the brain’s draining lymph nodes
(cervical lymph nodes, cLN), CR mice contained significantly fewer CD8+
and CD4+ T cells able to produce IFNc, a critically important antiviral
mediator, upon ex vivo peptide stimulation (Fig. 5B, C). Importantly, we
also tested whether the increased WNV mortality with CR was agespecific. We found that A mice on CR diet for 2 months also exhibited
significantly increased mortality after WNV infection compared to agematched controls (Fig. 5D). Overall, CR mice exhibited significantly
impaired T-cell function, consistent with the increased mortality in CR
mice. This is consistent with recent findings that the enormous metabolic
expenditure necessary to fuel strong primary effector T-cell responses
cannot tolerate dampening in either total calories (this paper) or the
mTOR axis activity (Goldberg et al., 2014).

Discussion
We have previously shown that age-related defects in CD8 and CD4 T
cells are associated with increased WNV-mediated mortality in mice
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(Brien et al., 2009). Therefore, when an immunosuppressive drug was
used to extend lifespan in mice (Harrison et al., 2009), we wondered
whether this could have deleterious consequences to the already
dysfunctional old T cells, particularly because we found that low-dose
rapa treatment results in increased mortality in A mice infected with
WNV (Goldberg et al., 2014). How rapa treatment would compare to
the long-term lifespan-extending intervention, CR, was not clear. CR has
been hypothesized to work, in part, by decreasing mTOR signaling
(Blagosklonny, 2010). However, increasing evidence suggests a more
complex interaction, whereby multiple pathways are likely altered by CR
to increase longevity.
We found a surprising and contrasting effect of CR and rapa on
thymic cellularity. The sensitivity of the old thymus to very low doses of
rapa was striking. One could speculate that this could be mediated by
hormonal changes induced by rapa, as we found increased serum
testosterone levels in the O rapa group, consistent with findings that
castration early in life preserves thymic cellularity (Radojevic et al., 2007).
However, increased testosterone was somewhat unexpected given a
previous report that rapa increases testicular degeneration in O mice
(Wilkinson et al., 2012), although in that study, testicular degeneration
was defined based on the effects on spermatogenesis, which is
independent of testosterone production (Cheng & Mruk, 2010); it
cannot be excluded that elevated testosterone could be leading to
testicular atrophy as well. Alternativelyn, Notch-induced activation of the
PI3K/AKT/mTOR signaling axis is indispensable for pre-T-cell glycolytic
metabolism and viability (Ciofani & Zuniga-Pflucker, 2005), so rapa could
drastically perturb the actively dividing T-cell precursors in an old thymus.
Furthermore, rapa treatment was shown to dysregulate thymocyte
development in vitro by decreasing proliferation and the transition from
the CD8-CD4- to the CD8 + CD4 + stage (Kelly et al., 2007). We
therefore speculate the deleterious effects of rapa on the aging thymus
are likely due to metabolic and cell survival defects, an issue that will
require additional research.
Beyond numerical reduction, there were no obvious specific blocks in
T-cell development among the four major thymocyte subsets. One
caveat to this interpretation is that we harvested tissue in the steady
state, after a 60-day treatment. Early effects of treatment may be quite
different (Fang et al., 2013). Indeed, at the onset of CR there is rapid
thymic cellularity loss, with subsequent restoration and ultimately
sustained cellularity increase during aging (Chen et al., 1998). Analogous studies using rapa have not been performed and would be highly
informative. The decreased thymic cellularity in rapa mice could also be
due to impaired emigration from the bone marrow, or decreased thymic
entry of thymocyte progenitors. Hematopoietic stem cells (HSCs) exhibit
depressed mTOR signaling to maintain quiescence. They also lose the
propensity to develop into lymphoid lineage, so additional mTOR
inhibition could further impair early T-cell precursor generation from
HSC, contributing to thymic defects. Additional experimentation is
needed to address either of these possibilities.
CR has been known to preserve a ‘young’ or na€ıve phenotype in the
aging immune system (Weindruch et al., 1982; Effros et al., 1991;
Messaoudi et al., 2006). Among our most surprising findings was that
the ‘younger’ phenotype of the thymus or the peripheral T cells of CR
mice did not translate to increased immune responses or better
protection during infection. While the peripheral CD8 T-cell pool had
an increased proportion of na€ıve cells (similar to our prior studies in
monkeys (Messaoudi et al., 2006) the absolute number of na€ıve CD8 T
cells was not increased in O CR mice compared to controls and that was
consistent with an unaltered spleen and lymph node TRECs content. We
would predict that rapa’s deleterious effect on the thymus would

eventually impose significant strain on the peripheral CD8 T-cell
repertoire in the course of long-term lifespan extension treatment.
Previous studies have shown that CR T cells are more responsive to
mitogen stimulation in vitro (Weindruch et al., 1982; Effros et al., 1991;
Messaoudi et al., 2006). Given that the percentage of na€ıve T cells,
which are the best responders to mitogenic stimulation, is significantly
higher in spleens of CR mice compared to ad libitum fed controls, these
results, which did not correct for such differences, can easily be
explained by unequal composition of the responding cells. It was not
known whether the above ‘improvement’ would translate to (i) better Tcell responses during infection and (ii) improved immune protection in
vivo. We found the opposite to be the case during WNV infection: CR
mice contained significantly fewer CD8 and CD4 T cells able to produce
IFNc in response to the virus, and this was associated with increased
susceptibility to disease. This was similar to previous reports on CR mice
infected with influenza virus (Gardner, 2005). However, unlike flu,
mortality from WNV infection is observed on days 9–15 postinfection,
and it is the failures in adaptive immunity that ultimately cause increased
susceptibility to WNV in O mice (Brien et al., 2009). Additionally, the
increased number of Tregs in O CR mice (Fig. 2B) could also limit the
expansion of responding CD4 and CD8 T cells during WNV infection
(Lanteri et al., 2009). Therefore, our data demonstrate that in addition
to innate defects (Ritz et al., 2008), O CR mice also exhibit adaptive
immune system defects, with a potential to lead to increased mortality
after acute infection. It would be of interest to know whether the
immune defects in O CR mice are permanently programed, or whether
they can be reversed by refeeding prior to infection (Clinthorne et al.,
2010). Additional studies are required to test whether refeeding or
alternate-day fasting can improve survival after infection, while retaining
the beneficial effects of CR. Furthermore, how CR or rapa alters T-cell
memory and vaccine efficacy have not been studied in aging, particularly
if initiated after a substantial fraction of immune memory has been
formed. As memory responses are a critical aspect of the adaptive
immune system, and rapa has been shown to enhance CD8 T-cell
memory, it will be of interest to investigate how these interventions
impact T-cell memory.
CR is thought to operate, at least in part, by decreasing mTORC1
signaling. However, it is increasingly clear that other pathways contribute to the overall health benefits observed in CR animals, likely including
insulin/insulin-like growth factor (IGF) signaling and AMP-activated
protein kinase (AMPK) activation, because O mice undergoing life
extension treated with rapa do not replicate benefits previously reported
for CR (Wilkinson et al., 2012; Neff et al., 2013). The likelihood that CR
operates by many mechanisms in addition to decreased mTORC1
signaling is further supported by a recent publication showing that the
two interventions have different metabolic outcomes in aged mice
(Miller et al., 2013). In the immune system, our data suggest that CR
may function via distinct, and perhaps entirely different, mechanism(s)
from rapa, as CR and rapa exhibited contrasting effects in almost every
analysis we performed. However, this issue requires additional research,
including accounting for the critical caveat that CR was a lifelong
intervention, whereas the rapa feeding began late in life.
While rapa and CR differentially affected the aging immune system,
changes induced by these agents were not beneficial and they each had
deleterious consequences to immunity. The negative effect of CR on
WNV infection susceptibility was clear. Rapa-treated groups showed
lower survival compared to controls, but the latter did not reach
statistical significance. However, we would argue that our model was
not optimally powered to statistically validate the subtler deleterious
effects of rapa. This is because most of our untreated O mice did not

ª 2014 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.

136 Life-prolonging CR and rapa erode immunity, E. L. Goldberg et al.
survive WNV infection, providing us with a very narrow window within
which to score increased susceptibility to WNV. In A mice rapa-induced
T-cell immunity defects correlated with lethal infection outcome
(Goldberg et al., 2014). On the basis of that and on the above results,
we conclude that neither CR nor rapa, in the doses and administration
regimens used in our study, may be ideal interventions for promoting
healthspan-associated longevity, stressing the need for better and more
successful rapalogues/substances manipulating the mTOR pathway.

Experimental procedures
Mice
Male A (16 weeks old) and O (16–18 months old) C57BL/6 mice were
purchased from Jackson Laboratories (Bar Harbor, ME) and the National
Institute on Aging (Charles River), respectively. Mice were housed in
sterile caging under specific pathogen-free conditions. All experimental
procedures were conducted with approval from the University of Arizona
Institutional Animal Care and Use Committee.

et al., 2011). For thymocyte gating, non-ab T-cell precursors were
excluded with a dump gate that included the following cell surface
markers: cd TCR, NK1.1, CD19, and B220. Samples were fixed and
permeabilized using the Foxp3 buffer kit (eBioscience, San Diego, CA,
USA) followed by intracellular staining. Samples were collected on a
custom LSR Fortessa flow cytometer (BD Biosciences, San Jose, CA, USA)
and analyzed using FLOWJO software (Tree Star, Ashland, OR, USA). All
antibodies were purchased from eBioscience, BD, and Invitrogen. DbNS4b tetramer was provided by the NIH tetramer core facility (Emory
University, Atlanta, GA, USA).

Quantitation of T-cell receptor excision circles and CD8 T-cell
precursors
Total CD8 T cells were enriched from spleen and superficial lymph nodes
using a negative selection kit (Miltenyi), normalized for cell counts,
pelleted, snap frozen, and stored at 80 °C until analysis. T-cell receptor
excision circle (TREC) quantitation was performed as described (Sempowski et al., 2002). CD8 T-cell precursors were enriched from spleen
and superficial lymph nodes as described previously (Rudd et al., 2011).

Calorie restriction
Old CR male mice were purchased from the NIA aged rodent colony. CR
is initiated at 14 weeks old, restricting 10% of food intake compared to
ad libitum controls, progressing to 25% at 15 weeks and 40% at
16 weeks, the level (3 g daily, NIH-31 fortified formula) maintained for
life. CR mice were purchased at the oldest available age and then housed
at the University of Arizona until 18 months old. For A CR studies, mice
were infected at 25 weeks of age (fully weaned on to the CR diet
2 months prior to infection).

Infection and vaccination
Mice were infected s.c. with 1000 pfu WNV strain 385-99 generously
provided by Dr. Robert Tesh (University of Texas Medical Branch,
Galveston). CD8 T-cell Ag-specific responses studied were restricted to
the CD8 immunodomonant epitope, NS4b; CD4 T-cell responses were
measured as the pooled response to 4 CD4 immunodominant epitopes:
E347, 2066, E641, and 1616, as in (Brien et al., 2009). Ex vivo
stimulation was performed in the presence of Brefeldin A, for 5 h at
37 °C.

Rapamycin treatment
Treatments with high-dose (LC Laboratories, Woburn, MA, USA; 2.5 mg
kg 1; daily i.p. injection) and low-dose injections (LC Laboratories; 75 lg
kg 1 daily) or low-dose chow (LC Laboratories, encapsulated in chow at
14 ppm by Southwest Research Institute, San Antonio, TX, USA,
formulated as described previously [Harrison et al., 2009)] rapa were
initiated 2 months prior to analysis or manipulation. All immunological
analyses and manipulations were performed in mice at least 18 months
old. Blood rapa concentrations were measured by HPLC–mass spectrometry exactly as described previously (Kusne et al., 2013). Rapa
concentrations were verified in paired samples by Dr. Martin Javors (UT
Health Science Center, San Antonio, TX, USA) by independent analysis
(Harrison et al., 2009).

Serum hormone measurements
Sera were collected from retro-orbital bleeds, following clotting on ice
for 30 min and were stored at 80 °C until analysis, with no freeze/
thaw cycles prior to analysis. Mouse testosterone levels were quantified
by ELISA (Enzo Life Sciences, Farmingdale, NY, USA) according to the
manufacturers’ instructions.

Flow cytometry
Blood samples were collected by retro-orbital bleed. Tissues were
harvested after isoflurane overdose followed by cardiac puncture.
Tetramer and flow cytometry staining and ex vivo peptide stimulation
for intracellular cytokine staining were performed as described (Smithey

Data analysis
Statistical analyses were performed using GRAPHPAD PRISM software
(GraphPad, La Jolla, CA, USA), as indicated in the text and legends.
Data were evaluated for normal distribution, and parametric or
nonparametric tests were used, as appropriate. P < 0.05 was considered
significant for all analyses.
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